XRN1 deletion induces PKR-dependent cell lethality in interferon-activated cancer cells

Cell Rep. 2024 Feb 27;43(2):113600. doi: 10.1016/j.celrep.2023.113600. Epub 2024 Jan 22.

Abstract

Emerging data suggest that induction of viral mimicry responses through activation of double-stranded RNA (dsRNA) sensors in cancer cells is a promising therapeutic strategy. One approach to induce viral mimicry is to target molecular regulators of dsRNA sensing pathways. Here, we show that the exoribonuclease XRN1 is a negative regulator of the dsRNA sensor protein kinase R (PKR) in cancer cells with high interferon-stimulated gene expression. XRN1 deletion causes PKR pathway activation and consequent cancer cell lethality. Disruption of interferon signaling with the JAK1/2 inhibitor ruxolitinib can decrease cellular PKR levels and rescue sensitivity to XRN1 deletion. Conversely, interferon-β stimulation can increase PKR levels and induce sensitivity to XRN1 inactivation. Lastly, XRN1 deletion causes accumulation of endogenous complementary sense/anti-sense RNAs, which may represent candidate PKR ligands. Our data demonstrate how XRN1 regulates PKR and how this interaction creates a vulnerability in cancer cells with an activated interferon cell state.

Keywords: CP: Cancer; CP: Immunology; PKR; RNA sensing; XRN1; cancer; interferon.

MeSH terms

  • Exoribonucleases / metabolism
  • Interferon-beta
  • Interferons*
  • Neoplasms* / genetics
  • Protein Kinases

Substances

  • Interferons
  • Interferon-beta
  • Exoribonucleases
  • Protein Kinases